Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Expression profiling of MCF7 cells upon Aminoflavone (AF) or Oncrasin1 (Onc1) treatment
PubMed Similar studies Analyze with GEO2R
Selective Targeting of PARP2 Inhibits Androgen Receptor Signaling and Prostate Cancer Growth Through Disruption of FOXA1 Function
PubMed Full text in PMC Similar studies
Genome-wide occupation of AR, FOXA1, and H3K27AC in LNCaP cells treated with selective PARP2 inhibitor UPF-1069
PubMed Full text in PMC Similar studies SRA Run Selector
Gene expression profilings for prostate cancer cells after inhibition of PARP1 or PARP2 using pharmaceutical or siRNA-based approaches
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
mTOR inhibitors suppress homologous recombination repair and synergize with PARP inhibitors via regulating SUV39H1 in BRCA-proficient triple-negative breast cancer
PubMed Full text in PMC Similar studies Analyze with GEO2R
Expression data from MDA-MB-231 cells treated with dinaciclib
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD)
Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
Murine Neural Stem/Progenitor Cells: Control vs.PJ34
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on